OncoMed Pharmaceuticals, Inc.
OMED
OMED was delisted on the 22nd of April, 2019.
83 hedge funds and large institutions have $248M invested in OncoMed Pharmaceuticals, Inc. in 2015 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 37 increasing their positions, 20 reducing their positions, and 12 closing their positions.
200% more funds holding in top 10
Funds holding in top 10: 1 → 3 (+2)
85% more repeat investments, than reductions
Existing positions increased: 37 | Existing positions reduced: 20
48% more call options, than puts
Call options by funds: $3.19M | Put options by funds: $2.16M
40% more capital invested
Capital invested by funds: $177M → $248M (+$71.4M)
5% less funds holding
Funds holding: 87 → 83 (-4)
33% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 12
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
IHM
Iguana Healthcare Management
New York
|
+$5.63M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$3.74M |
| 3 |
ASP
Adams Street Partners
Chicago,
Illinois
|
+$3.61M |
| 4 |
Balyasny Asset Management
Chicago,
Illinois
|
+$3.6M |
| 5 |
VAM
Visium Asset Management
New York
|
+$3.34M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BI
BVF Inc
San Francisco,
California
|
-$7.88M |
| 2 |
ICM
IronBridge Capital Management
Oakbrook Terrace,
Illinois
|
-$3.03M |
| 3 |
Millennium Management
New York
|
-$1.99M |
| 4 |
SAM
Sectoral Asset Management
Montreal,
Quebec, Canada
|
-$1.81M |
| 5 |
Prudential Financial
Newark,
New Jersey
|
-$1.49M |
OMED Hedge Fund Activity: Q4 2015 in Review
83 of the 3,824 institutional investors tracked by Wall St. Rank reported a position in OncoMed Pharmaceuticals, Inc. (OMED) for Q4 2015, worth a combined $248M — up 40% from $177M a quarter earlier.
Sellers outnumbered buyers: 12 funds closed out of OMED and 8 opened new positions — a net loss of 4 holders — while 20 trimmed existing stakes and 37 added.
The largest buyer was Iguana Healthcare Management, adding an estimated $5.63M. The largest seller was BVF Inc, cutting an estimated $7.88M.
- 83 institutional investors held OncoMed Pharmaceuticals, Inc. (OMED) as of Q4 2015, down from 87 in Q3 2015.
- Funds reported $248M of OncoMed Pharmaceuticals, Inc. stock for Q4 2015, up 40% quarter-over-quarter.
- 8 funds opened new OncoMed Pharmaceuticals, Inc. positions in Q4 2015 and 12 closed out, a net change of -4 holders.
- The largest OncoMed Pharmaceuticals, Inc. buyer in Q4 2015 was Iguana Healthcare Management, an estimated $5.63M added.
- The largest OncoMed Pharmaceuticals, Inc. seller in Q4 2015 was BVF Inc, an estimated $7.88M sold.
Based on aggregated 13F filings for Q4 2015.